Category

Therapeutic Areas

Home > Therapeutic Areas (Page 56)

Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MA, Torres C, Yebenes M, Quintana M, Alvarez-Sabín J

 

 

Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in Stroke Units in Spain
Health Qual Life Outcomes. 2015;13:36. doi: 10.1186/s12955-015-0230-8

Roncero C, Domínguez-Hernández R, Díaz T, Fernández JM, Forcada R, Martínez JM, Seijo P, Terán A, Oyagüez I

 

 

Manejo de pacientes dependientes de opiáceos: Comparación del coste asociado al uso de buprenorfina/naloxona o metadona, y sus interacciones con tratamientos concomitantes para comorbilidades infecciosas o psiquiátricas
Adicciones. 2015;27(3):179-89

Villarrubia R, Oyagüez I, Alvarez-Roman MT, Mingot-Castellano ME, Parra R, Casado MA

 

 

Cost analysis of prophylaxis with activated prothrombin complex concéntrate versus on-demand therapy with activated factor VII in severe hemophilia A patients with inhibitors, in Spain
Haemophilia. 2015;21(3):320-9

Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G

 

 

Impact of dynamic microbiological environment on the clinical efficacy of ertapenem and piperacillin/tazobactam in the treatment of complicated community-acquired intra-abdominal infection in Spain: A cost-consequence analysis
Appl Health Econ Health Policy. 2015;13(4):369-79

Arevalo JM, Lozano V, Oyagüez I, Casado MA

 

 

 

Surgical treatment of pressure ulcers with a fibrin sealant in patients with spinal cord injury: A cost-consequence analysis
Adv Skin Wound Care. 2015;28(11):503-7

De Andrés-Nogales F, Oyagüez I, Betegón-Nicolás L, Canal-Fontcuberta C, Soto-Álvarez J

 

 

Situación del tratamiento anticoagulante oral en pacientes con fibrilación auricular no valvular en España. Estudio REACT-AF
Rev Clin Esp. 2015;215(2):73-82